Emery Corinne, Dinet Jérôme, Lafuma Antoine, Sermet Catherine, Khoshnood Babak, Fagnani Francis
Cemka-Eval, Bourg-La-Reine.
Presse Med. 2007 Jun;36(6 Pt 1):832-40. doi: 10.1016/j.lpm.2006.12.031. Epub 2007 Feb 27.
To estimate the costs associated with obesity in France.
We used data from the 2002 survey on health and social protection as well as health care consumption data from the EPAS sample of the national health insurance funds. After excluding those younger than 18 years, pregnant women and people diagnosed with cancer, we classified subjects as underweight, normal weight, or obese and then studied two subpopulations: (P1) obese patients (body mass index (BMI) >or= 30 kg/m2) and (P2) patients who were obese or overweight (BMI >or= 27 kg/m2) and had additional cardiovascular risk factors: hypertension, dyslipidemia, type 2 diabetes, myocardial infarction (present or history), transient ischemic attack, intermittent claudication or sleep apnea. The Heckman approach was used to adjust for several factors.
The study included 4651 individuals, with a mean age was 47 years. The obesity prevalence rate was estimated at 10.7% for P1; the P2 prevalence was 16.0%. Average healthcare costs for the entire study group were 1534 euro, 1105 euro for ambulatory care (72%) and 429 euro (28%) for inpatient care. Costs for obese subjects (P1 and P2) averaged 2500 euro, twice the costs for normal-weight people (1263 euro). After taking into account age, sex, socioeconomic status, alcohol consumption and smoking, the 100% reimbursement rate for chronic diseases (all else being equal), the extra cost of obesity, compared with normal weight, was estimated between 506 euro (P1) and 648 euro (P2).
The annual total cost of obesity was estimated to range from 2.1 to 6.2 billion euros in 2002 and account for 1.5 to 4.6% of total health expenditures in France.
估算法国肥胖相关的成本。
我们使用了2002年健康与社会保护调查的数据以及国家医疗保险基金EPAS样本中的医疗保健消费数据。在排除18岁以下人群、孕妇和被诊断患有癌症的人群后，我们将受试者分为体重过轻、正常体重或肥胖，并研究了两个亚组：（P1）肥胖患者（体重指数（BMI）≥30 kg/m²）和（P2）肥胖或超重（BMI≥27 kg/m²）且有其他心血管危险因素的患者：高血压、血脂异常、2型糖尿病、心肌梗死（现患或病史）、短暂性脑缺血发作、间歇性跛行或睡眠呼吸暂停。采用赫克曼方法对多个因素进行调整。
该研究纳入了4651名个体，平均年龄为47岁。P1的肥胖患病率估计为10.7%；P2的患病率为16.0%。整个研究组的平均医疗费用为1534欧元，门诊护理费用为1105欧元（72%），住院护理费用为429欧元（28%）。肥胖受试者（P1和P2）的费用平均为2500欧元，是正常体重者（1263欧元）费用的两倍。在考虑年龄、性别、社会经济地位、饮酒和吸烟、慢性病100%报销率（其他条件相同）后，与正常体重相比，肥胖的额外成本估计在506欧元（P1）至648欧元（P2）之间。
2002年肥胖的年度总成本估计在21亿至62亿欧元之间，占法国总卫生支出的1.5%至4.6%。
